Adamis Pharmaceuticals Corp - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ADMP Nasdaq 2834 http://www.adamispharmaceuticals.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Adamis Pharmaceuticals Corp

Adamis Pharmaceuticals Provides Business Update - Aug 27th, 2018 10:02 am
Mylan’s EpiPen Supply Shortages Continue: What to Expect Ahead - Aug 17th, 2018 8:30 am
Teva Gets FDA Nod for First Generic Version of Mylan's EpiPen - Aug 17th, 2018 7:25 am
Today’s Research Reports on Stocks to Watch: Antares Pharma and Adamis Pharmaceuticals - Aug 17th, 2018 6:00 am
FDA Approves Teva’s Generic Version of EpiPen, Stock Up 7.5% - Aug 16th, 2018 3:02 pm
FDA approves first rival generic EpiPen, sending Teva shares up 6% - Aug 16th, 2018 11:25 am
Adamis Pharmaceuticals (ADMP) Reports Q2 Loss, Misses Revenue Estimates - Aug 10th, 2018 8:15 am
Adamis: 2Q Earnings Snapshot - Aug 10th, 2018 7:09 am
Adamis Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Update - Aug 10th, 2018 7:00 am
Adamis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full - Aug 6th, 2018 2:05 pm
Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock - Aug 2nd, 2018 7:00 am
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock - Aug 1st, 2018 2:03 pm
Market Trends Toward New Normal in Horizon Global, Bio-Techne, Adamis Pharmaceuticals, Kadant, Semgroup, and Provident Financial Services — Emerging Consolidated Expectations, Analyst Ratings - Aug 1st, 2018 6:30 am
Adamis Pharmaceuticals Adds Sublingual Erectile Dysfunction Product Candidate to its Pipeline - Jul 23rd, 2018 7:00 am
Pharma Stock Roundup: NVS to Divest Eye Care Unit, CHMP Gives Nod to Several Drugs - Jul 6th, 2018 7:16 am
Adamis (ADMP) Surges Following Novartis Deal for Symjepi - Jul 3rd, 2018 6:41 am
Today's Research Reports on Stocks to Watch: Adamis Pharmaceuticals and MiMedx - Jul 3rd, 2018 6:00 am
Adamis has a partner to market its EpiPen competitor after a year-long search - Jul 3rd, 2018 4:51 am
[$$] Novartis Injects Itself Into Planned Rollout of EpiPen Competitor - Jul 2nd, 2018 5:46 pm
Adamis Pharmaceuticals Rose Almost 35% Early on July 2 - Jul 2nd, 2018 10:31 am